ABBV vs NEOG · P/E 81, rev $16.99B vs rev $870.4M
AbbVie Inc (ABBV) versus Neogen Corporation (NEOG) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Neogen Corporation (NEOG) is a diagnostics & research company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported NEOG revenue for 2026-05-31 was $870.4M. Net income was -$7.9M. Revenue was down 2.7% from 2025-05-31 to 2026-05-31. NEOG currently screens at market cap $1.03B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. NEOG currently screens at market cap $1.03B.
Not investment advice. Open the ABBV and NEOG stock pages for the full models.
Not investment advice.